The recent AstraZeneca tax dispute settlement has been well-documented. But not much has been said about what the settlement means for other taxpayers and their dealings with HM Revenue & Customs (HMRC).
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
Two months since EU political agreement on pillar two and few member states have made progress on new national laws, but the arrival of OECD technical guidance should quicken the pace. Ralph Cunningham reports.